Milestone Pharmaceuticals (MIST) Total Liabilities: 2021-2022
Historic Total Liabilities for Milestone Pharmaceuticals (MIST) over the last 2 years, with Sep 2022 value amounting to $8.6 million.
- Milestone Pharmaceuticals' Total Liabilities rose 35.46% to $8.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $8.6 million, marking a year-over-year increase of 35.46%. This contributed to the annual value of $7.2 million for FY2021, which is N/A change from last year.
- Per Milestone Pharmaceuticals' latest filing, its Total Liabilities stood at $8.6 million for Q3 2022, which was up 85.65% from $4.6 million recorded in Q2 2022.
- Over the past 5 years, Milestone Pharmaceuticals' Total Liabilities peaked at $8.6 million during Q3 2022, and registered a low of $4.6 million during Q2 2022.
- Moreover, its 2-year median value for Total Liabilities was $6.4 million (2021), whereas its average is $6.3 million.
- Data for Milestone Pharmaceuticals' Total Liabilities shows a peak YoY increase of 35.46% (in 2022) and a maximum YoY decrease of 21.83% (in 2022) over the last 5 years.
- Quarterly analysis of 2 years shows Milestone Pharmaceuticals' Total Liabilities stood at $7.2 million in 2021, then skyrocketed by 35.46% to $8.6 million in 2022.
- Its Total Liabilities was $8.6 million in Q3 2022, compared to $4.6 million in Q2 2022 and $5.0 million in Q1 2022.